• Egg Lecithin, Phosphatidylcholine in Lecithin, Soy Lecithin
• ]]>Alzheimer's Disease]]>, ]]>Bipolar Disorder]]>, ]]>High Cholesterol]]>, ]]>Liver Disease]]>, ]]>Parkinson's Disease]]>, ]]>Tardive Dyskinesia]]>, Tourette's Syndrome, ]]>Ulcerative Colitis]]>
For decades, lecithin has been a popular treatment for high cholesterol (although there is surprisingly little evidence that it works). More recently, lecithin has been proposed as a remedy for various psychological and neurological diseases, such as Tourette's syndrome, Alzheimer's disease, and bipolar disorder (also known as manic depression).
Lecithin contains a substance called phosphatidylcholine (PC) that is presumed to be responsible for its medicinal effects. Phosphatidylcholine is a major part of the membranes surrounding our cells. However, when you consume this substance it is broken down into the nutrient choline rather than being carried directly to cell membranes. Choline acts like folate, TMG (trimethylglycine), and SAMe (S-adenosylmethionine) to promote methylation. (See the article on ]]>TMG]]> for further discussion of this subject.) It is also used to make acetylcholine , a nerve chemical essential for proper brain function.
This article discusses lecithin and phosphatidylcholine. For more information on the effects and possible benefits of ]]>Choline]]> alone, see the full article on that subject.
Neither lecithin nor its ingredient phosphatidylcholine is an essential nutrient; however, choline]]> has recently been recognized as essential. For use as a supplement or a food additive, lecithin is often manufactured from soy.
Ordinary lecithin contains about 10% to 20% phosphatidylcholine. However, European research has tended to use products concentrated to contain 90% phosphatidylcholine in lecithin, and the following dosages are based on that type of product. For psychological and neurological conditions, doses as high as 5 to 10 g taken three times daily have been used in studies. For liver disease, a typical dose is 350 to 500 mg taken three times daily; for high cholesterol, 500 to 900 mg taken three times daily has been tried.
For a while, lecithin/phosphatidylcholine was one of the most commonly recommended natural treatments for high cholesterol]]> . However, this idea appears to rest entirely on studies of unacceptably low quality. ]]>2,25]]> The best designed studies have failed to find any evidence of benefit. ]]>3,25-28]]> In Europe, phosphatidylcholine is also used to treat ]]>liver diseases]]> , such as alcoholic fatty liver, ]]>alcoholic hepatitis]]> , ]]>liver cirrhosis]]> , and ]]>viral hepatitis]]> . However, research into these potential uses remains preliminary and has yielded contradictory results. ]]>4-14]]>
Researchers have recently become interested in the use of phosphadylcholine as a supportive treatment in severe ]]>ulcerative colitis]]> . There may be an insufficient quantity of phosphatidylcholine in the mucus lining the colon in patients with ulcerative colitis. Taking phosphatidylcholine may correct this deficiency. A small double-blind, placebo controlled study of 60 patients whose ulcerative colitis was poorly responsive to corticosteroids were randomized to receive either phosphadylcholine (2 g per day) or placebo for 12 weeks. ]]>31]]> Half of the participants taking phosphadylcholine showed a significant improvement in symptoms versus only 10% taking placebo. Moreover, 80% taking phosphadylcholine were able to completely discontinue their corticosteroids without disease flare-up compared to 10% taking placebo.
Because phosphatidylcholine plays a role in nerve function, it has also been suggested as a treatment for various psychological and neurological disorders, such as ]]>Alzheimer's disease]]> , ]]>bipolar disorder]]> , ]]>Parkinson's disease]]> , Tourette's syndrome, and ]]>tardive dyskinesia]]> (a late-developing side effect of drugs used for psychosis). However, the evidence that it works is limited to small studies with conflicting results. ]]>15-24,30]]>
Lecithin is believed to be generally safe. However, some people taking high dosages (several grams daily) experience minor but annoying side effects, such as abdominal discomfort, diarrhea, and nausea. Maximum safe dosages for young children, pregnant or nursing women, or those with severe liver or kidney disease have not been determined.
3. Oosthuizen W, Vorster HH, Vermaak, WJ, et al. Lecithin has no effect on serum lipoprotein, plasma fibrinogen and macro molecular protein complex levels in hyperlipidaemic men in a double-blind controlled study. Eur J Clin Nutr . 1998;52:419-424.
4. Buchman AL, Dubin M, Jenden D, et al. Lecithin increases plasma free choline and decreases hepatic steatosis in long-term total parenteral nutrition patients. Gastroenterology . 1992;102:1363-1370.
10. Schuller-Perez A, Gonzalez San Martin F. A controlled study with polyunsaturated phosphatidylcholine compared to placebo in alcoholic steatosis of the liver [translated from German]. Med Welt . 1985;36:517-521.
11. Knuchel F. Double-blind study in patients with alcoholic toxic fatty liver. Effect of essential phospholipids on enzyme behavior and lipid composition of the serum [translated from German]. Med Welt . 1979;30:411-416.
12. Jenkins PJ, Portmann BP, Eddleston AL, et al. Use of polyunsaturated phosphatidylcholine in HBsAg negative chronic active hepatitis: results of prospective double-blind controlled trial. Liver . 1982;2:77-81.
13. Niederau C, Strohmeyer G, Heintges T, et al. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Hepatogastroenterology. 1998;45:797-804.
15. Stoll AL, Sachs GS, Cohen BM, et al. Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patients. Biol Psychiatry . 1996;40:382-388.
27. Childs MT, et al. The contrasting effects of a dietary soya lecithin product and corn oil on lipoprotein lipids in normolipidemic and familial hypercholesterolemic subjects. Atherosclerosis . 198;38:217-228.
29. Olthof MR, Brink EJ, Katan MB, et al. Choline supplemented as phosphatidylcholine decreases fasting and postmethionine-loading plasma homocysteine concentrations in healthy men. Am J Clin Nutr. 2005;82:111-117.
Last reviewed April 2009 by EBSCO CAM Review Board]]>
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © 2007 EBSCO Publishing All rights reserved.